Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03313999 · ClinicalTrials.gov registry record · NA
Measuring Skin Elasticity in Lymphedema Patients
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03313999 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT03313999, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This protocol will utilize the lymphedema indentometer, or durometer (a novel, noninvasive piece of equipment that measures skin elasticity), to better characterize disease progression in patients with lymphedema. Beth Israel Deaconess Medical Center patients who undergo treatment of lymphedema will be candidates for this noninvasive test. This device and the data it generates will help understand the incidence of lymphedema at Beth Israel Deaconess Medical Center compared to national data and the outcomes of surgical treatment of lymphedema.
Interventions
- DEVICE Lymphedema Indentometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-02-18 |
| Est. Completion | 2025-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03313999
The ClinicalTrials.gov registry entry for NCT03313999 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lymphedema Indentometer is the first listed.
NCT03313999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03313999 about?
NCT03313999 is a clinical study titled "Measuring Skin Elasticity in Lymphedema Patients". This protocol will utilize the lymphedema indentometer, or durometer (a novel, noninvasive piece of equipment that measures skin elasticity), to better characterize disease progression in patients with lymphedema. Beth Israel Deaconess Medical Center patients who undergo treatment of lymphedema will...
What is the current status of trial NCT03313999?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2018-02-18. Estimated completion is 2025-06-02.
What interventions are being tested in trial NCT03313999?
The interventions under investigation include: Lymphedema Indentometer (DEVICE).
Who is sponsoring clinical trial NCT03313999?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.